Clinical Trial Update: A Study to Evaluate the Safety of Hydronidone Capsules in Patients With Liver Fibrosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the safety of Hydronidone capsules in patients with chronic hepatitis B and hepatic fibrosis, and the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Fibrosis
• Hepatitis B

Drugs mentioned

• Hydronidone (Hydronidone)

Snippet

Sponsor: Beijing Continent Pharmaceutical Co, Ltd. | Conditions: Chronic Hepatitis B With Hepatic Fibrosis | Phase 2 | Status: RECRUITING